These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36930296)

  • 1. Spinal astrocyte dysfunction drives motor neuron loss in late-onset spinal muscular atrophy.
    Schmitt LI; David C; Steffen R; Hezel S; Roos A; Schara-Schmidt U; Kleinschnitz C; Leo M; Hagenacker T
    Acta Neuropathol; 2023 May; 145(5):611-635. PubMed ID: 36930296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of Survival of Motor Neuron (SMN) Protein Deficiency in Spinal Astrocytes by Small Interfering RNA as an In Vitro Model of Spinal Muscular Atrophy.
    Leo M; Schmitt LI; Fleischer M; Steffen R; Osswald C; Kleinschnitz C; Hagenacker T
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminished motor neuron activity driven by abnormal astrocytic EAAT1 glutamate transporter activity in spinal muscular atrophy is not fully restored after lentiviral SMN delivery.
    Welby E; Ebert AD
    Glia; 2023 May; 71(5):1311-1332. PubMed ID: 36655314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocyte-produced miR-146a as a mediator of motor neuron loss in spinal muscular atrophy.
    Sison SL; Patitucci TN; Seminary ER; Villalon E; Lorson CL; Ebert AD
    Hum Mol Genet; 2017 Sep; 26(17):3409-3420. PubMed ID: 28637335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased Motor Neuron Support by SMA Astrocytes due to Diminished MCP1 Secretion.
    Martin JE; Nguyen TT; Grunseich C; Nofziger JH; Lee PR; Fields D; Fischbeck KH; Foran E
    J Neurosci; 2017 May; 37(21):5309-5318. PubMed ID: 28450545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch Signaling Mediates Astrocyte Abnormality in Spinal Muscular Atrophy Model Systems.
    Ohuchi K; Funato M; Yoshino Y; Ando S; Inagaki S; Sato A; Kawase C; Seki J; Saito T; Nishio H; Nakamura S; Shimazawa M; Kaneko H; Hara H
    Sci Rep; 2019 Mar; 9(1):3701. PubMed ID: 30842449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMN deficiency does not induce oxidative stress in SMA iPSC-derived astrocytes or motor neurons.
    Patitucci TN; Ebert AD
    Hum Mol Genet; 2016 Feb; 25(3):514-23. PubMed ID: 26643950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calpain Inhibition Increases SMN Protein in Spinal Cord Motoneurons and Ameliorates the Spinal Muscular Atrophy Phenotype in Mice.
    de la Fuente S; Sansa A; Periyakaruppiah A; Garcera A; Soler RM
    Mol Neurobiol; 2019 Jun; 56(6):4414-4427. PubMed ID: 30327977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astrocytes influence the severity of spinal muscular atrophy.
    Rindt H; Feng Z; Mazzasette C; Glascock JJ; Valdivia D; Pyles N; Crawford TO; Swoboda KJ; Patitucci TN; Ebert AD; Sumner CJ; Ko CP; Lorson CL
    Hum Mol Genet; 2015 Jul; 24(14):4094-102. PubMed ID: 25911676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calpain system is altered in survival motor neuron-reduced cells from in vitro and in vivo spinal muscular atrophy models.
    de la Fuente S; Sansa A; Hidalgo I; Vivancos N; Romero-Guevara R; Garcera A; Soler RM
    Cell Death Dis; 2020 Jun; 11(6):487. PubMed ID: 32587237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy.
    Dachs E; Piedrafita L; Hereu M; Esquerda JE; Calderó J
    Neuroscience; 2013 Oct; 250():417-33. PubMed ID: 23876328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice.
    Tsai LK; Tsai MS; Ting CH; Li H
    J Mol Med (Berl); 2008 Nov; 86(11):1243-54. PubMed ID: 18649067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective loss of alpha motor neurons with sparing of gamma motor neurons and spinal cord cholinergic neurons in a mouse model of spinal muscular atrophy.
    Powis RA; Gillingwater TH
    J Anat; 2016 Mar; 228(3):443-51. PubMed ID: 26576026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal motor neuron loss occurs through a p53-and-p21-independent mechanism in the Smn
    Reedich EJ; Kalski M; Armijo N; Cox GA; DiDonato CJ
    Exp Neurol; 2021 Mar; 337():113587. PubMed ID: 33382987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice.
    Dominguez E; Marais T; Chatauret N; Benkhelifa-Ziyyat S; Duque S; Ravassard P; Carcenac R; Astord S; Pereira de Moura A; Voit T; Barkats M
    Hum Mol Genet; 2011 Feb; 20(4):681-93. PubMed ID: 21118896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms involved in spinal cord central synapse loss in a mouse model of spinal muscular atrophy.
    Tarabal O; Caraballo-Miralles V; Cardona-Rossinyol A; Correa FJ; Olmos G; Lladó J; Esquerda JE; Calderó J
    J Neuropathol Exp Neurol; 2014 Jun; 73(6):519-35. PubMed ID: 24806302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
    Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
    Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular pathways involved in cell survival are deregulated in mouse and human spinal muscular atrophy motoneurons.
    Sansa A; de la Fuente S; Comella JX; Garcera A; Soler RM
    Neurobiol Dis; 2021 Jul; 155():105366. PubMed ID: 33845129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loganin possesses neuroprotective properties, restores SMN protein and activates protein synthesis positive regulator Akt/mTOR in experimental models of spinal muscular atrophy.
    Tseng YT; Chen CS; Jong YJ; Chang FR; Lo YC
    Pharmacol Res; 2016 Sep; 111():58-75. PubMed ID: 27241020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Free Circulating Messenger Ribonucleic Acids in Serum Samples from Late-Onset Spinal Muscular Atrophy Patients Using nCounter NanoString Technology.
    Leo M; Schmitt LI; Mairinger F; Roos A; Hansmann C; Hezel S; Skuljec J; Pul R; Schara-Schmidt U; Kleinschnitz C; Hagenacker T
    Cells; 2023 Sep; 12(19):. PubMed ID: 37830588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.